𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Circulating tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in proliferative diabetic retinopathy: a pilot study

✍ Scribed by A.J. Simpson; N.A. Booth; N.R. Moore; S.J. Lewis; R.S. Gray

Publisher
Springer
Year
1999
Tongue
English
Weight
45 KB
Volume
36
Category
Article
ISSN
0940-5429

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR I
TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR IN HUMAN RENAL CELL CARCINOMA
✍ WAGNER, STEPHAN N.; ATKINSON, MICHAEL J.; THANNER, STEPHANIE; SCHMITT, MANFRED; πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 597 KB

In experimental models, plasminogen activator-mediated degradation of the extracellular matrix is inhibited by type-1 plasminogen activator inhibitor (PAI-1). PA14 has also been shown to protect tumour stromal tissue from autoproteolytic activities and may thus substantially promote tumour growth an